PPA
ADMA icon

Parametric Portfolio Associates’s ADMA Biologics ADMA Stock Holding History

Parametric Portfolio Associates’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-147,855
Closed -$237K – 3601
2021
Q2 		$237K Buy
147,855
+113,797
+334% +$200K ﹤0.01% 3346
2021
Q1 		$60K Buy
34,058
+14,931
+78% +$34.2K ﹤0.01% 4012
2020
Q4 		$37K Buy
+19,127
New +$40.2K ﹤0.01% 3960
2020
Q3 		– Sell
-12,697
Closed -$37K – 3924
2020
Q2 		$37K Buy
12,697
+1,449
+13% +$4.16K ﹤0.01% 3880
2020
Q1 		$32K Sell
11,248
-7,905
-41% -$27.3K ﹤0.01% 3870
2019
Q4 		$77K Buy
19,153
+3,902
+26% +$17K ﹤0.01% 3887
2019
Q3 		$68K Buy
15,251
+2,707
+22% +$11.3K ﹤0.01% 3878
2019
Q2 		$49K Buy
+12,544
New +$55.4K ﹤0.01% 3910

Other funds holding ADMA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return